Patent 7666844 was granted and assigned to Novo Nordisk on February, 2010 by the United States Patent and Trademark Office.
Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.